|1.||Plopper, George E: 2 articles (09/2011 - 07/2008)|
|2.||Peters, Joop A: 2 articles (02/2011 - 01/2007)|
|3.||Djanashvili, Kristina: 2 articles (02/2011 - 01/2007)|
|4.||Koning, Gerben A: 2 articles (02/2011 - 01/2007)|
|5.||Kim, Jihoon: 1 article (01/2016)|
|6.||Kim, Jinhwan: 1 article (01/2016)|
|7.||Park, Dongsik: 1 article (01/2016)|
|8.||Lee, Yeong Mi: 1 article (01/2016)|
|9.||Kim, Hyunwoo: 1 article (01/2016)|
|10.||Kim, Won Jong: 1 article (01/2016)|
02/01/2011 - "Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate."
01/01/2016 - "Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy."
01/01/2015 - "In particular, the phenylboronic acid-functionalized nanocarriers for specific targeting to sialic acid groups which are overexpressed on tumor cells have made great achievements. "
05/22/2013 - "Dual-responsive surfaces modified with phenylboronic acid-containing polymer brush to reversibly capture and release cancer cells."
09/01/2011 - "Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration."
|2.||Prostatic Neoplasms (Prostate Cancer)
|4.||Breast Neoplasms (Breast Cancer)
01/01/2015 - "BC-11 is an easily synthesized simple thiouronium-substituted phenylboronic acid, which has been shown to be cytotoxic on triple negative MDA-MB231 breast cancer cells by inducing a perturbation of cell cycle when administered at a concentration equal to its ED50 at 72 h (117 μM). "
07/01/2008 - "Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability."
07/01/2008 - "We compared the in vitro effect of boric acid (BA) versus phenylboronic acid (PBA) on the migration of prostate and breast cancer cell lines and non-tumorigenic cells from the same tissues. "
07/01/2015 - "The results strongly suggest that NADPH oxidase-mediated peroxynitrite drove TLR4 recruitment into hepatic lipid rafts and inflammation, whereas the in vivo use of the peroxynitrite scavenger phenylboronic acid, a novel synthetic molecule having high reactivity with peroxynitrite, attenuates inflammatory pathogenesis in NASH. "
|1.||Biological Markers (Surrogate Marker)
|2.||Proteins (Proteins, Gene)
|5.||N-Acetylneuraminic Acid (Sialic Acid)
|7.||boric acid (boron oxide hydroxide)
|8.||Peroxynitrous Acid (Peroxynitrite)
|9.||NADPH Oxidase (NAD(P)H oxidase)
|10.||Silicon Dioxide (Sand)
|1.||Quantum Dots (Quantum Dot)